Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307053
What this trial is testing

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

Who this might be right for
Rare Malignant NeoplasmAdvanced Solid TumorsMetastatic Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT00589472
What this trial is testing

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00003087
What this trial is testing

Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center 25
Not applicableStudy completedNCT04876599
What this trial is testing

Mind-body Resiliency Intervention for Fear of Cancer Recurrence

Who this might be right for
CancerCoping SkillsCoping Behavior
Massachusetts General Hospital 64
Large-scale testing (Phase 3)Active Not RecruitingNCT03531099
What this trial is testing

Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 108
Not applicableEnded earlyNCT03560102
What this trial is testing

Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer

Who this might be right for
Breast Cancer, Invasive Ductal
Kantonsspital Winterthur KSW 1
Not applicableStudy completedNCT00950144
What this trial is testing

Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer

Who this might be right for
Colorectal CancerDepressionFatigue+3 more
City of Hope Medical Center 123
Not applicableActive Not RecruitingNCT04541030
What this trial is testing

Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 241
Testing effectiveness (Phase 2)Study completedNCT05510895
What this trial is testing

Neoadjuvant Encorafenib, Binimetinib and Cetuximab for Patients With BRAF V600E Mutated/pMMR Localized Colorectal Cancer

Who this might be right for
Colorectal CancerColon CancerBRAF V600E+2 more
AIO-Studien-gGmbH 2
Testing effectiveness (Phase 2)Ended earlyNCT02874430
What this trial is testing

Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer

Who this might be right for
Breast CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 29
Testing effectiveness (Phase 2)WithdrawnNCT01636128
What this trial is testing

Urinary Biomarker Study With Sulindac and Difluoromethylornithine

Who this might be right for
Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms
Cancer Prevention Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Ended earlyNCT00005075
What this trial is testing

Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
EDAP Technomed
Large-scale testing (Phase 3)Study completedNCT03138512
What this trial is testing

A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney

Who this might be right for
Carcinoma, Renal Cell
Bristol-Myers Squibb 1,641
Large-scale testing (Phase 3)Study completedNCT00025428
What this trial is testing

Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma

Who this might be right for
Neuroblastoma
Societe Internationale d'Oncologie Pediatrique 100
Not applicableUnknownNCT02809495
What this trial is testing

Digital Application Usage for Adherence of Patients Undergoing Robotic Assisted Radical Prostatectomy Following Oncological and Postoperative Functional Outcomes

Who this might be right for
the Focus of This Study is to Develop an Application for Postoperative Follow-up of Patients With Prostate Cancer
University of Sao Paulo General Hospital 100
Large-scale testing (Phase 3)Study completedNCT04549675
What this trial is testing

Couple-focused Intervention for Sun Protection

Who this might be right for
Skin Cancer Prevention
Rutgers, The State University of New Jersey 150
Testing effectiveness (Phase 2)Looking for participantsNCT07185165
What this trial is testing

An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

Who this might be right for
Prostate Carcinoma
Jonsson Comprehensive Cancer Center 81
Not applicableStudy completedNCT01407731
What this trial is testing

Protein Expression in Human Neuroblastoma Tumor Samples

Who this might be right for
Neuroblastoma
Children's Oncology Group 20
Testing effectiveness (Phase 2)Ended earlyNCT00923247
What this trial is testing

A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)

Who this might be right for
Medullary Thyroid Carcinoma
National Cancer Institute (NCI) 22
Next Page